PXN and breast carcinoma: Previous research indicates that Y118-Paxillin phosphorylation levels are inversely correlated with cancer metastasis in breast cancer patient tissue samples (Madan et al., 2006), suggesting that, similar to our findings, Y118-Paxillin phosphorylation does not correlate with an invasive phenotype.